摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S*,3aS*,14bS*)-1,2,3,5,6,8,9,14b-octahydro-1-hydroxy-2,2-dimethoxy-4H-cyclopenta[a]-1,3-dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepine | 107672-49-1

中文名称
——
中文别名
——
英文名称
(1S*,3aS*,14bS*)-1,2,3,5,6,8,9,14b-octahydro-1-hydroxy-2,2-dimethoxy-4H-cyclopenta[a]-1,3-dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepine
(1S*,3aS*,14bS*)-1,2,3,5,6,8,9,14b-octahydro-1-hydroxy-2,2-dimethoxy-4H-cyclopenta[a]-1,3-dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepine化学式
CAS
107672-49-1
化学式
C19H25NO5
mdl
——
分子量
347.411
InChiKey
LCBWDBFFKICMDR-RCCFBDPRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.64
  • 重原子数:
    25.0
  • 可旋转键数:
    2.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    60.39
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Total synthesis of (±)-cephalotaxine
    作者:Hiroyuki Ishibashi、Masahiko Okano、Hiroshi Tamaki、Kazumi Maruyama、Takayuki Yakura、Masazumi Ikeda
    DOI:10.1039/c39900001436
    日期:——
    A total synthesis of (±)-cephalotaxine has been achieved in a stereoselective manner by a synthetic sequence involving an acid-catalysed cyclisation of the α-sulphinylacetamide 12 as a key step.
    (±)-头孢他辛的全合成已经通过立体选择的方式实现,该合成顺序涉及一个关键步骤,该合成序列涉及酸催化的α-亚磺酰基乙酰胺12的环化。
  • Formal Total Synthesis of (±)-Cephalotaxine and Congeners via Aryne Insertion Reaction
    作者:Pashikanti Gouthami、Rambabu Chegondi、Srivari Chandrasekhar
    DOI:10.1021/acs.orglett.6b00659
    日期:2016.5.6
    The formal total synthesis of pentacyclic core alkaloid, (±)-cephalotaxine is achieved in nine steps from known 2-allylpyrrolidine-2-carboxaldehyde using aryne insertion reaction as a key step in 10% overall yield. The developed novel strategy enabled easy access to cephalotaxine congeners.
    五环核心生物碱(±)-头孢他辛的正式全合成是通过使用芳烃插入反应作为关键步骤从已知的2-allylpyrrolidine-2-car甲醛从九个步骤完成的,实现了10%的总收率。发达的新颖策略使人们容易接近头孢他辛同源物。
  • A total synthesis of (.+-.)-cephalotaxinamide.
    作者:Shingo Yasuda、Youichi Yamamoto、Shuji Yoshida、Miyoji Hanaoka
    DOI:10.1248/cpb.36.4229
    日期:——
    (±)-Cephalotaxinamide (6) was synthesized from pyroglutamic acid via the pyrrolobenzazepine (4) through the Claisen rearrangement, the Wacker oxidation, aldol condensation, and hydroxylation with iodosobenzene.
    (±)-Cephalotaxinamide (6)是由焦谷酸通过吡咯并氮杂卓(4)经克莱森重排、瓦克氧化、醛醇缩合和碘苯羟基化反应合成的。
查看更多

同类化合物

高三尖杉酯碱酰胺 高三尖杉酯碱 氧桥三尖杉碱 异三尖杉酯碱 双(去甲基)-脱氧三尖杉酯碱 去甲基三尖杉酮碱 去氧哈林通碱 乙酰三尖杉碱 三尖杉酯碱 三尖杉酯碱 三尖杉碱 4-羟基三尖杉碱 4'-去甲基高三尖杉酯碱 (1S,3aR)-1,5,6,8,9,14bbeta-六氢-2-甲氧基-4H-环戊并[a][1,3]二氧杂环戊并[4,5-H]吡咯并[2,1-b][3]苯并氮杂卓-1alpha,9alpha-二醇 (-)-脱水三尖杉酯碱 (2S,3R,4S,5S,7R)-2,3-dihydroxy-7-methyl-cephalotaxan-8-one (2R,3S,4S,5S)-2,3-dihydroxy-8-oxocephalotaxane (+/-)-D-homocephalotaxine Desmethyldiacetyl-cephalotaxin (3aα,4S*,10β,15bβ,15cα)-(+/-)-10-acetoxy-3a,4,6,7,9,10,15b,15c-octahydro-2,2-dimethyl-5H-<1,3>dioxolo<4,5-h>-1,3-dioxolo<4,5>cyclopenta<1,2-a>pyrrolo<2,1-b><3>benzazepine Cephalotaxyl 6,6-dimethyl-5,6-dihydropyran-1-carboxylate 3t-phenyl-acrylic acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester 6-O-(4-methylimidazole-3-carbonyl)2,6-diacetylhomoharringtonine 6-O-(2-chloropyridin-3-carbonyl)2,6-diacetylhomoharringtonine (Ξ)-methylsuccinic acid 1-((3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl) ester 4-methyl ester 6-O-(phenylacetyl)2,6-diacetylhomoharringtonine 6-O-(furan-2-carbonyl)2,6-diacetylhomoharringtonine succinic acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester methyl ester O-3-[(2R)-2,6-dihydroxy-2-(2'-cyclohexaneamino-2'-oxoethyl)-6-methylheptanoyl]cephalotaxine (2R,7R)-17,19-dioxa-11-azapentacyclo[12.7.0.02,7.07,11.016,20]henicosa-1(21),4,12,14,16(20)-pentaen-10-one Acetic acid 6-((1aR,2aS,5aR,6S,6aS)-5-methyl-4-oxo-octahydro-1-oxa-5-aza-cyclopropa[f]inden-6-yl)-benzo[1,3]dioxol-5-ylmethyl ester (Ξ)-(3-methyl-butyl)-succinic acid 1-((3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl) ester 4-methyl ester 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-[4-methyl-4-(4-methyl-1,3-thiazole-5-carbonyl)oxypentyl]-2-(4-methyl-1,3-thiazole-5-carbonyl)oxybutanedioate 3,8-dioxocephalotax-1-ene furan-3,4-dicarboxylic acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester methyl ester 2α,3α-dihydroxycephalotaxan-8-one 2,3-dehydrocephalotaxan-8-one 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-[4-(cyclohexanecarbonyloxy)-4-methylpentyl]-2-hydroxybutanedioate 2α,3α-epoxycephalotaxan-8-one [(2S,3R,4S,6S)-3-acetyloxy-9-oxo-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),13,15(19)-trien-4-yl] acetate (3-methyl-butyl)-butenedioic acid 1-((3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl) ester 4-methyl ester benzyl ((2S,3S,3aR)-2,3-dihydroxy-2,3,5,6,8,9-hexahydro-4H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-1-yl) carbonate 3t-(4-nitro-phenyl)-acrylic acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester (2R,3S,4S,5S)-2-(tert-butyldimethylsililoxy)-3-hydroxy-8-oxocephalotaxane